These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 15582534)
1. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. Lin HK; Steckelbroeck S; Fung KM; Jones AN; Penning TM Steroids; 2004 Dec; 69(13-14):795-801. PubMed ID: 15582534 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286 [TBL] [Abstract][Full Text] [Related]
3. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3). Penning TM; Burczynski ME; Jez JM; Lin HK; Ma H; Moore M; Ratnam K; Palackal N Mol Cell Endocrinol; 2001 Jan; 171(1-2):137-49. PubMed ID: 11165022 [TBL] [Abstract][Full Text] [Related]
4. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Penning TM; Burczynski ME; Jez JM; Hung CF; Lin HK; Ma H; Moore M; Palackal N; Ratnam K Biochem J; 2000 Oct; 351(Pt 1):67-77. PubMed ID: 10998348 [TBL] [Abstract][Full Text] [Related]
5. Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors. Penning TM; Steckelbroeck S; Bauman DR; Miller MW; Jin Y; Peehl DM; Fung KM; Lin HK Mol Cell Endocrinol; 2006 Mar; 248(1-2):182-91. PubMed ID: 16417966 [TBL] [Abstract][Full Text] [Related]
6. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221 [TBL] [Abstract][Full Text] [Related]
7. Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary system. Azzarello J; Fung KM; Lin HK J Histochem Cytochem; 2008 Sep; 56(9):853-61. PubMed ID: 18574251 [TBL] [Abstract][Full Text] [Related]
8. AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids. Skarydová L; Zivná L; Xiong G; Maser E; Wsól V Chem Biol Interact; 2009 Mar; 178(1-3):138-44. PubMed ID: 19007764 [TBL] [Abstract][Full Text] [Related]
9. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Ji Q; Aoyama C; Nien YD; Liu PI; Chen PK; Chang L; Stanczyk FZ; Stolz A Cancer Res; 2004 Oct; 64(20):7610-7. PubMed ID: 15492289 [TBL] [Abstract][Full Text] [Related]
10. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547 [TBL] [Abstract][Full Text] [Related]
11. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. Ji Q; Chang L; VanDenBerg D; Stanczyk FZ; Stolz A Prostate; 2003 Mar; 54(4):275-89. PubMed ID: 12539226 [TBL] [Abstract][Full Text] [Related]
12. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5. Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815 [TBL] [Abstract][Full Text] [Related]
13. Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. Lewis MJ; Wiebe JP; Heathcote JG BMC Cancer; 2004 Jun; 4():27. PubMed ID: 15212687 [TBL] [Abstract][Full Text] [Related]
14. Paracrine-stimulated gene expression profile favors estradiol production in breast tumors. Amin SA; Huang CC; Reierstad S; Lin Z; Arbieva Z; Wiley E; Saborian H; Haynes B; Cotterill H; Dowsett M; Bulun SE Mol Cell Endocrinol; 2006 Jul; 253(1-2):44-55. PubMed ID: 16735089 [TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution. Lin HK; Jez JM; Schlegel BP; Peehl DM; Pachter JA; Penning TM Mol Endocrinol; 1997 Dec; 11(13):1971-84. PubMed ID: 9415401 [TBL] [Abstract][Full Text] [Related]
16. Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells. Rizner TL; Lin HK; Penning TM Chem Biol Interact; 2003 Feb; 143-144():401-9. PubMed ID: 12604227 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a highly specific monoclonal antibody against human aldo-keto reductase AKR1C3. Liu J; He P; Lin L; Zhao Y; Deng W; Ding H; Li Q; Wang Z Steroids; 2019 Mar; 143():73-79. PubMed ID: 30639543 [TBL] [Abstract][Full Text] [Related]
18. Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis. Hevir N; Vouk K; Sinkovec J; Ribič-Pucelj M; Rižner TL Chem Biol Interact; 2011 May; 191(1-3):217-26. PubMed ID: 21232532 [TBL] [Abstract][Full Text] [Related]
19. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. Rizner TL; Smuc T; Rupreht R; Sinkovec J; Penning TM Mol Cell Endocrinol; 2006 Mar; 248(1-2):126-35. PubMed ID: 16338060 [TBL] [Abstract][Full Text] [Related]
20. Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid. Steckelbroeck S; Jin Y; Oyesanmi B; Kloosterboer HJ; Penning TM Mol Pharmacol; 2004 Dec; 66(6):1702-11. PubMed ID: 15383625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]